General trans-diagnostic late effects of cancer and cancer treatment
| dc.contributor.author | Buskbjerg, Cecilie Rask | |
| dc.contributor.author | Amidi, Ali | |
| dc.contributor.author | Wu, Lisa M. | |
| dc.contributor.author | Ventzel, Lise | |
| dc.contributor.author | Lyhne, Johanne Dam | |
| dc.contributor.author | Christiansen, Peer | |
| dc.contributor.author | Christensen, Peter | |
| dc.contributor.author | Jensen, Anders Bonde | |
| dc.contributor.author | Offersen, Birgitte | |
| dc.contributor.author | Johansen, Christoffer | |
| dc.contributor.author | Zachariae, Bobby | |
| dc.contributor.department | Sálfræðideild | |
| dc.date.accessioned | 2026-10-09T11:00:01Z | |
| dc.date.available | 2026-10-09T11:00:01Z | |
| dc.date.issued | 2026-05-11 | |
| dc.description | Published under Open Access CC-BY-NC-ND 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/. | en |
| dc.description.abstract | Many of the growing population of cancer survivors experience general biopsychosocial late effects, including depression, fear of recurrence, insomnia, fatigue, cognitive difficulties, and chronic pain, with a substantial impact on quality of life and functioning. This review finds evidence for psychological, behavioural, physical, and selected pharmacological interventions. Recently developed Danish clinical practice guidelines provide evidence-based recommendations for assessment and treatment, highlighting the need for coordinated, cross-sectoral implementation to ensure equitable, high-quality survivorship care. | en |
| dc.description.version | Peer reviewed | en |
| dc.format.extent | 8 | |
| dc.format.extent | 324475 | |
| dc.format.extent | 1-8 | |
| dc.identifier.citation | Buskbjerg, C R, Amidi, A, Wu, L M, Ventzel, L, Lyhne, J D, Christiansen, P, Christensen, P, Jensen, A B, Offersen, B, Johansen, C & Zachariae, B 2026, 'General trans-diagnostic late effects of cancer and cancer treatment', Ugeskrift for Læger, vol. 2026, no. 20, V01260017, pp. 1-8. https://doi.org/10.61409/V01260017 | en |
| dc.identifier.doi | 10.61409/V01260017 | |
| dc.identifier.issn | 1603-6824 | |
| dc.identifier.other | 251174130 | |
| dc.identifier.other | 6c6c6006-6282-4ff9-a8ee-475ac5db492f | |
| dc.identifier.other | ORCID: /0000-0003-2241-9905/work/217119898 | |
| dc.identifier.other | 105040332396 | |
| dc.identifier.other | 42186896 | |
| dc.identifier.other | unpaywall: 10.61409/v01260017 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.11815/8606 | |
| dc.language.iso | da | |
| dc.relation.ispartofseries | Ugeskrift for Læger; 2026(20) | en |
| dc.relation.url | https://www.scopus.com/pages/publications/105040332396 | en |
| dc.rights | info:eu-repo/semantics/openAccess | en |
| dc.subject | Cancer Survivors/psychology | en |
| dc.subject | Humans | en |
| dc.subject | Neoplasms/complications | en |
| dc.subject | Practice Guidelines as Topic | en |
| dc.title | General trans-diagnostic late effects of cancer and cancer treatment | da |
| dc.title.alternative | General trans-diagnostic late effects of cancer and cancer treatment | en |
| dc.type | /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article | en |
Skrár
Original bundle
1 - 1 af 1
- Nafn:
- V01260017_WEB.pdf
- Stærð:
- 316.87 KB
- Snið:
- Adobe Portable Document Format